ImmunoPrecise Antibodies Ltd. IPA

Quarterly report 2026-Q3
added 05-16-2026

Country	Canada
IPO year	-
Industry	-
Stock Exchange	NASDAQ GLOBAL

Shares	33.4 M
Market Cap^[1]	$ 40.8 M
EBITDA (LTM)	-
P/E (LTM)	-
P/S (LTM)	2.32
EPS (LTM)	-2.7

References

Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.